Enzene Biosciences

Enzene Biosciences is a global CDMO dedicated to bringing affordable, high-quality biologics and biosimilars to market. The company has revolutionized biologics production through its patented and validated continuous bioprocess manufacturing platform, EnzeneX®, which significantly reduces production costs for complex biologics and monoclonal antibodies (mAbs).

Core Services

Drug Discovery & Development:

• Target identification and validation
• Antibody discovery and engineering
• Custom reagents and assay development
• Cell line development
• Process development
• Formulation development
• Analytical methods and CMC support
• Product characterization and bioassay capability
• Stability studies

Manufacturing:

• Drug substance manufacturing
• Drug product manufacturing
• Technology transfer and scale-up
• Quality assurance and control
• Regulatory affairs support

Specialized Capabilities:

• EnzeneX® continuous manufacturing platform for cost reduction
• Biosimilar development and comparability testing
• AAV technology licensing
• Animal health solutions
• NeX™ suite for local biomanufacturing

Locations & Expansion

Established sites in India with strong focus on USA and Europe. Recently developed new R&D and manufacturing facility near Princeton, New Jersey, aimed at providing cost-effective local manufacturing for early-stage biological assets.

Recognition

Great Place to Work (GPTW) certified for 5 consecutive years. Winner of 2025 CPHI Pharma Award for Manufacturing Excellence.